Covalon Technologies Ltd. (TSXV:COV)
Canada
· Delayed Price · Currency is CAD | Market Cap | 51.65M |
| Revenue (ttm) | 31.54M |
| Net Income (ttm) | 977.42K |
| Shares Out | 27.62M |
| EPS (ttm) | 0.03 |
| PE Ratio | 54.41 |
| Forward PE | 21.37 |
| Dividend | 0.15 (7.85%) |
| Ex-Dividend Date | Nov 4, 2025 |
| Volume | 3,111 |
| Average Volume | 23,562 |
| Open | 1.900 |
| Previous Close | 1.910 |
| Day's Range | 1.860 - 1.910 |
| 52-Week Range | 1.550 - 3.100 |
| Beta | -0.06 |
| RSI | 62.76 |
| Earnings Date | Feb 25, 2026 |
About Covalon Technologies
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company’s platform technologies comprises collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secon... [Read more]
Financial Performance
In fiscal year 2025, Covalon Technologies's revenue was 32.82 million, an increase of 5.29% compared to the previous year's 31.17 million. Earnings were 2.06 million, a decrease of -22.91%.
Financial StatementsNews
Covalon Technologies Ltd. 2026 Q1 - Results - Earnings Call Presentation
Covalon Technologies Ltd (CVALF) Q1 2026 Earnings Call Highlights: Navigating Revenue ...
Covalon Technologies Ltd (CVALF) Q1 2026 Earnings Call Highlights: Navigating Revenue Challenges with Strategic Growth Initiatives
Covalon Technologies Ltd. (COV:CA) Q1 2026 Earnings Call Transcript
Q1 2026 Covalon Technologies Ltd Earnings Call Transcript
Q1 2026 Covalon Technologies Ltd Earnings Call Transcript
Covalon Technologies Ltd Q1 Earnings Summary
(RTTNews) - Below are the earnings highlights for Covalon Technologies Ltd (COV.V):
Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first...
Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving patient safety an...
Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q1 Fiscal 2026 resul...
Covalon Technologies Ltd. 2025 Q4 - Results - Earnings Call Presentation
Covalon Technologies Ltd (CVALF) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ...
Covalon Technologies Ltd (CVALF) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Amid Challenges
Q4 2025 Covalon Technologies Ltd Earnings Call Transcript
Q4 2025 Covalon Technologies Ltd Earnings Call Transcript
Covalon Technologies Ltd. (COV:CA) Q4 2025 Earnings Call Transcript
Covalon Technologies Ltd. (COV:CA) Q4 2025 Earnings Call Transcript
Covalon Technologies GAAP EPS of $0.01, revenue of $8.69M
Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 fourt...
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fisc...
Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the payment on Novemb...
Covalon Declares First Ever Special Cash Dividend
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that its Board of Dir...
Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company improving lives through innovative wou...
Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet & Pathway Conference
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving patient safety an...
Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation in the As...
Covalon Announces Departure of Executive Chair and the Appointment of its Largest Shareholder as New Chair
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that Mr. Abe Schwartz...
Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon's Presence at the Association for Vascular Access 2025 Annual Meeting
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation at the As...
Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the publication of re...